Spero Legacy Sti, Inc.
Part of Spero Therapeutics, Inc.
- UEI
- VV22G4K3AZC4
- CAGE
- 6WYX2
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
-
Its parent company, Spero Therapeutics, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Cambridge, MA
NX34PL7NZW24
-
Parent
Cambridge, MA
NX34PL7NZW24
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Quick answers
Is Spero Legacy Sti, Inc. registered in SAM.gov?
Spero Legacy Sti, Inc.'s SAM.gov registration expired on December 12, 2020.
What is Spero Legacy Sti, Inc.'s CAGE code?
Spero Legacy Sti, Inc.'s CAGE code is 6WYX2, and its Unique Entity ID (UEI) is VV22G4K3AZC4.
How does Spero Legacy Sti, Inc. rank among federal contractors?
Spero Legacy Sti, Inc.'s parent company, Spero Therapeutics, Inc., ranked #44 in PSC AN13 and #59 in NAICS 541714 in FY2025.
What is Spero Legacy Sti, Inc.'s most recent federal award?
Spero Legacy Sti, Inc.'s most recent federal grant award is A novel gyrase inhibitor for the treatment of drug-susceptible and multidrug-resistant mycobacterium tuberculosis… (R44AI131749), from National Institute of Allergy and Infectious Diseases (NIH), on March 1, 2017.
On GovTribe
See Spero Legacy Sti, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors